177 related articles for article (PubMed ID: 22705971)
21. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
22. Roles played by acidic lipids in HIV-1 Gag membrane binding.
Olety B; Ono A
Virus Res; 2014 Nov; 193():108-15. PubMed ID: 24998886
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of PI(4,5)P2 Enrichment in HIV-1 Viral Membranes.
Wen Y; Feigenson GW; Vogt VM; Dick RA
J Mol Biol; 2020 Sep; 432(19):5343-5364. PubMed ID: 32739462
[TBL] [Abstract][Full Text] [Related]
24. Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.
Mercredi PY; Bucca N; Loeliger B; Gaines CR; Mehta M; Bhargava P; Tedbury PR; Charlier L; Floquet N; Muriaux D; Favard C; Sanders CR; Freed EO; Marchant J; Summers MF
J Mol Biol; 2016 Apr; 428(8):1637-55. PubMed ID: 26992353
[TBL] [Abstract][Full Text] [Related]
25. Relationships between MA-RNA Binding in Cells and Suppression of HIV-1 Gag Mislocalization to Intracellular Membranes.
Thornhill D; Olety B; Ono A
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511376
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 matrix protein binding to RNA.
Alfadhli A; McNett H; Tsagli S; Bächinger HP; Peyton DH; Barklis E
J Mol Biol; 2011 Jul; 410(4):653-66. PubMed ID: 21762806
[TBL] [Abstract][Full Text] [Related]
27. RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production.
Ramalingam D; Duclair S; Datta SA; Ellington A; Rein A; Prasad VR
J Virol; 2011 Jan; 85(1):305-14. PubMed ID: 20980522
[TBL] [Abstract][Full Text] [Related]
28. The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding.
Camus G; Segura-Morales C; Molle D; Lopez-Vergès S; Begon-Pescia C; Cazevieille C; Schu P; Bertrand E; Berlioz-Torrent C; Basyuk E
Mol Biol Cell; 2007 Aug; 18(8):3193-203. PubMed ID: 17538020
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
[TBL] [Abstract][Full Text] [Related]
30. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
[TBL] [Abstract][Full Text] [Related]
31. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.
Scarlata S; Ehrlich LS; Carter CA
J Mol Biol; 1998 Mar; 277(2):161-9. PubMed ID: 9514761
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 matrix-tRNA complex structure reveals basis for host control of Gag localization.
Bou-Nader C; Muecksch F; Brown JB; Gordon JM; York A; Peng C; Ghirlando R; Summers MF; Bieniasz PD; Zhang J
Cell Host Microbe; 2021 Sep; 29(9):1421-1436.e7. PubMed ID: 34384537
[TBL] [Abstract][Full Text] [Related]
33. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.
Lee SK; Harris J; Swanstrom R
J Virol; 2009 Sep; 83(17):8536-43. PubMed ID: 19515760
[TBL] [Abstract][Full Text] [Related]
34. NMR, biophysical, and biochemical studies reveal the minimal Calmodulin binding domain of the HIV-1 matrix protein.
Samal AB; Ghanam RH; Fernandez TF; Monroe EB; Saad JS
J Biol Chem; 2011 Sep; 286(38):33533-43. PubMed ID: 21799007
[TBL] [Abstract][Full Text] [Related]
35. Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.
Caccuri F; Giagulli C; Reichelt J; Martorelli D; Marsico S; Bugatti A; Barone I; Rusnati M; Guzman CA; Dolcetti R; Caruso A
J Virol; 2014 May; 88(10):5706-17. PubMed ID: 24623414
[TBL] [Abstract][Full Text] [Related]
36. Solution structure of calmodulin bound to the binding domain of the HIV-1 matrix protein.
Vlach J; Samal AB; Saad JS
J Biol Chem; 2014 Mar; 289(12):8697-705. PubMed ID: 24500712
[TBL] [Abstract][Full Text] [Related]
37. Phosphatidylinositol-(4,5)-Bisphosphate Acyl Chains Differentiate Membrane Binding of HIV-1 Gag from That of the Phospholipase Cδ1 Pleckstrin Homology Domain.
Olety B; Veatch SL; Ono A
J Virol; 2015 Aug; 89(15):7861-73. PubMed ID: 25995263
[TBL] [Abstract][Full Text] [Related]
38. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.
Jones CP; Datta SA; Rein A; Rouzina I; Musier-Forsyth K
J Virol; 2011 Feb; 85(4):1594-603. PubMed ID: 21123373
[TBL] [Abstract][Full Text] [Related]
39. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
Poon DT; Li G; Aldovini A
J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
[TBL] [Abstract][Full Text] [Related]
40. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
Cimarelli A; Luban J
J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
